Abstract 3909: THY1 regulates therapy resistance in glioblastoma recurrence
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-3909
Abstract: Glioblastoma (GBM), is the most common primary brain tumor. It is a lethal disease with a median survival of 15 months characterized by treatment resistance, aggressive brain invasion, and inevitable recurrence. Less than 10 percent… read more here.
Keywords: thy1; glioblastoma; thy1 expression; recurrence ... See more keywords